Anti-PD1 Antibodies + IDO Inhibitor and Other Treatments in Melanoma May Be in Clinical Practice within One Year
Lawrence Fong, MD of University of California, San Francisco discusses upcoming combination therapies for melanoma treatment that will be FDA approved and used in clinical practice at the ASCO-SITC Cl...
Author: ASCO-SITC2017
Added: 03/06/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts